Dr. Charles Cleeland, PHD

Validation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting, 2022-08-12

Utility of Patient-Reported Symptom and Functional Outcomes to Indicate Recovery after First 90 Days of Radical Cystectomy: A Longitudinal Study, 2023-06-04

Caregiver symptom burden: the risk of caring for an underserved patient with advanced cancer, 2010-10-19

Factors Affecting Symptom Presentation in an Early-Phase Clinical Trials Clinic Patient Population, 2019-11-25

Patient-reported symptom interference as a measure of postsurgery functional recovery in lung cancer, 2016-08-10

Socioeconomic status is associated with depressive severity among patients with advanced non-small cell lung cancer: Treatment setting and minority status do not make a difference, 2015-07-22

Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial, 2019-04-29

Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65 years old, 2017-11-23

Symptom Burden in Cancer Survivors One Year after Diagnosis: A Report from the American Cancer Society's Studies of Cancer Survivors, 2011-04-14

Linguistic validation of the Greek M.D. Anderson Symptom Inventory - Head and Neck Module, 2012-05-17

Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Radiotherapy (IMRT) for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes, 2016-02-18

The validity and utility of the M.D. Anderson Symptom Inventory in patients with prostate cancer: evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology Group, 2013-10-12

Longitudinal Analysis of Patient-Reported Symptoms Post-AuSCT and their Relationship to Inflammation in Patients with Multiple Myeloma, 2014-11-20

Measuring therapy-induced peripheral neuropathy: preliminary development and validation of the Treatment-induced Neuropathy Assessment Scale (TNAS), 2015-07-22

Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-small Cell Lung Cancer: A Phase II Randomized Trial, 2019-10-15

The Symptom Burden of Treatment-Naive Patients with Head and Neck Cancer, 2014-11-04

Serum sTNFR1, IL6, and the Development of Fatigue in Patients with Gastrointestinal Cancer Undergoing Chemoradiation Therapy, 2012-01-10

Symptom recovery after thoracic surgery: measuring patient-reported outcomes with the MD Anderson Symptom Inventory, 2015-05-28

Subclinical Pre-Treatment Sensory Deficits Appear to Predict the Development of Pain and Numbnessin Patients with Multiple Myeloma Undergoing Chemotherapy, 2013-03-31

Predictors of Significant Worsening of Patient-Reported Fatigue over a One-Month Timeframe in Ambulatory Patients with Common Solid Tumors, 2013-10-21

Development of a Patient-reported Outcome Tool for Assessing Symptom Burden during Perioperative Care in Liver Surgery: The MDASI-PeriOp-Hep, 2021-04-28

Validation and Application of a Module of the MD Anderson Symptom Inventory for Measuring Perioperative Symptom Burden in Patients with Gynecologic Cancer (MDASI-PeriOp-GYN), 2018-11-28

Prechemotherapy Touch-Sensation Deficits Predict Oxaliplatin-Induced Neuropathy in Patients with Colorectal Cancer, 2016-02-17

High Symptom Burden Prior to Radiation Therapy for Head and Neck Cancer: A Patient-Reported Outcomes Study, 2012-11-20

Assessment of physical function by subjective and objective methods in patients undergoing open gynecologic surgery, 2021-01-31

Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65 years old, 2017-09-09

Racial/Ethnic Disparities in Inflammatory Gene SNPs as Predictors of High Risk for Symptom Burden in Patients with Multiple Myeloma 1 Year Post-Diagnosis, 2014-12-02

Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer, 2013-01-31

Measuring symptoms as a critical component of drug development and evaluation in hematological diseases, 2013-12-01

Minocycline for Symptom Reduction during Oxaliplatin-Based Chemotherapy for Colorectal Cancer: A Phase II Randomized Clinical Trial, 2019-06-26

Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer, 2013-05-15

Translational approaches to treatment-induced symptoms in cancer patients, 2012-05-29

Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy, 2013-03-09

Higher stem cell dose infusion after intensive chemotherapy does not improve symptom burden in older patients with multiple myeloma and amyloidosis, 2015-08-05

The Utility of Patient Reported Outcome Measures among Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, 2016-09-06

Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM), 2019-06-17

Patient-Reported Lung Symptoms as an Early Signal of Impending Radiation Pneumonitis in Patients with Non-Small Cell Lung Cancer Treated with Chemoradiation: An Observational Study, 2018-03-16

Patterns of Symptom Burden During Radiation Therapy or Concurrent Chemoradiation for Head and Neck Cancer: A Prospective Analysis Using the MD Anderson Symptom Inventory-Head and Neck Module, 2014-04-07

Temporal patterns of fatigue predict pathological response in patients treated with preoperative chemoradiation therapy for rectal cancer, 2009-02-21

Validation of the M. D. Anderson Symptom Inventory multiple myeloma module, 2013-02-05

The Validity and Utility of the M. D. Anderson Symptom Inventory in Patients With Breast Cancer: Evidence From the Symptom Outcomes and Practice Patterns Data From the Eastern Cooperative Oncology Group, 2013-06-28

A Randomized, Placebo-Controlled, Double-Blind Study of Minocycline for Reducing the Symptom Burden Experienced by Patients with Advanced Pancreatic Cancer, 2020-01-24

The symptom burden of cancer: evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group's Symptom Outcomes and Practice Patterns Study, 2013-09-24

Anastrozole-Associated Joint Pain and Other Symptoms in Patients With Breast Cancer, 2012-12-18

The Treatment-induced Neuropathy Assessment Scale (TNAS): a psychometric update following qualitative enrichment, 2020-02-19

Prevalence and characteristics of moderate-to-severe fatigue: a multicenter study in cancer patients and survivors, 2014-02-01

Patient-reported symptoms at discharge and risk of complications after gynecologic surgery, 2023-02-06

Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation, 2014-01-14

Nomogram for predicting symptom severity during radiation therapy for head and neck cancer, 2014-08-07

Automated Pain Intervention for Underserved Minority Women with Breast Cancer, 2015-02-24

Changes in pain and other symptoms in patients with painful multiple myeloma-related vertebral fracture treated with kyphoplasty or vertebroplasty, 2012-04-28

Measuring the Symptom Burden of Lung Cancer: The Validity and Utility of the Lung Cancer Module of the M. D. Anderson Symptom Inventory, 2011-02-01

A prospective analysis of the clinical effects of stereotactic body radiation therapy in cancer patients with spinal metastases without spinal cord compression, 2012-01-27

Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma, 2017-03-23